Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain

NCT00649610 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Low Back Pain

Interventions

DRUG: valdecoxib
DRUG: diclofenac

Sponsor

Pfizer